Current Issue

Volume 3, Issue 2, Summer 2024
					View Volume 3, Issue 2, Summer 2024
  • Mantle Cell Lymphoma: Evolving Frontline Treatment Strategies
  • Therapy for Myelodysplastic Syndromes Beyond the Front Line in 2024 in Canada
  • Management of Chronic Myeloid Leukemia that is Intolerant or Resistant to Front-line Treatment
  • High-Risk Myeloma: Definitions and Treatments
  • Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure
Published: 2024-06-27
View All Issues